Atlas Trials

A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers

Clinical trial NCT01972893 · COMPLETED

Trial details

NCT number
NCT01972893
Sponsor
Zydus Lifesciences Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2011-02-01
Primary completion
2012-03-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.